Sign In | Join Free | My frbiz.com
frbiz.com
Products
Search by Category
Home > Other Food & Beverage >

health care product nutrition supplement breviscapine with best price

Categories Herbal medicine powder
Brand Name: complex
Model Number: BGH-218
Certification: ISO9001/Halal/Kosher
Place of Origin: china
MOQ: 1kg
Price: US$825-830/kg
Payment Terms: L/C, D/A, D/P, T/T, Western Union, MoneyGram
Supply Ability: 5000000kg per year
Delivery Time: 3 workdays after payment
Packaging Details: 1kg 5kg 25kg two plastic bag inside,aluminum foil bag or drum outside
Type: Herbal Extract
Variety: breviscapine
Form: Powder
Part: bark
Packaging: Drum
Place of origin: Shaanxi,China(Mainland)
Key word: breviscapine
Color: White powder
Water soluble: good water soluble
  • Haven't found right suppliers
  • Our buyer assistants can help you find the most suitable, 100% reliable suppliers from China.
  • And this service is free of charge.
  • we have buyer assistants who speak English, French, Spanish......and we are ready to help you anytime!
Submit Buying Request
  • Product Details
  • Company Profile

health care product nutrition supplement breviscapine with best price

health care product nutrition supplement breviscapine with best price
product details

Product name:Erigeron breviscapus Extract

Extract source:Bergenia purpurascens.
Specification:98%

Active ingredient:Breviscapine

Used Part:flower

CAS NO. : 116122-36-2

Molecular formula :C21H18O12

Molecular weight:462.4

Appearance:light yellow Powder

Flavor: Characteristic taste

Particle Size:80% pass through 80 mesh sieve

Test mothed: HPLC

Extract Solvent: Ethanol & Water

Solubility: Soluble in water, ethanol

Usage: Pharmaceuticals, healthcares,and cosmetics




Product Description
Breviscapine is a mixture of flavonoid glycosides extracted from the Chinese herbs. Previous studies have shown that breviscapine possesses comprehensive pharmacological functions. However, very little is known about whether breviscapine have protective role on cardiac hypertrophy. The aim of the present study was to determine whether breviscapine attenuates cardiac hypertrophy induced by angiotensin II (Ang II) in cultured neonatal rat cardiac myocytes in vitro and pressure-overload-induced cardiac hypertrophy in mice in vivo. Our data demonstrated that breviscapine (2.5-15 microM) dose-dependently blocked cardiac hypertrophy induced by Ang II (1 microM) in vitro. The results further revealed that breviscapine (50 mg/kg/day) prevented cardiac hypertrophy induced by aortic banding as assessed by heart weight/body weight and lung weight/body weight ratios, echocardiographic parameters, and gene expression of hypertrophic markers. The inhibitory effect of breviscapine on cardiac hypertrophy is mediated by disrupting PKC-alpha-dependent ERK1/2 and PI3K/AKT signaling. Further studies showed that breviscapine inhibited inflammation by blocking NF-kappaB signaling, and attenuated fibrosis and collagen synthesis through abrogating Smad2/3 signaling. Therefore, these findings indicate that breviscapine, which is a potentially safe and inexpensive therapy for clinical use, has protective potential in targeting cardiac hypertrophy and fibrosis through suppression of PKC-alpha-dependent signaling.

Product Analysis


ItemSpecificationResultMethod
BasicProduct Information
Product namebreviscapine
Part of the PlantflowerConform/
Country of OriginChinaConform/
Organoleptic Data
AppearanceFine powderConformNLS-QCS-1008
ColorLight yellow powderConformGB/T 5492-2008
Odor& TasteCharacteristicConformGB/T 5492-2008
Process Data
Solvent(s) UsedWater and ethyl alcoholConform/
Extract ration/Conform
ContentPaeoniflorin≥98%98.18
Drying MethodSpray dryingConform/
ExcipientMaltodextrinConform/
Physical Characteristics
Particle Size (80 mesh)98.0%pass 80meshConformGB/T 5507-2008
Moisture<5.0%2.8%GB/T 14769-1993
Ash Content<4.0%1.4%AOAC 942.05, 18th
Solvent ResidueEur. PharmConformNLS-QCS-1007
Heavy Metals
Total Heavy Metals<10 ppmConformUSP <231>, method II
Arsenic<1.0 ppmConformAOAC 986.15, 18th
Lead<1.0 ppmConformAOAC 986.15, 18th
Mercury<0.5 ppmConformAOAC 971.21, 18th
Pesticide Residue
666<0.2ppmConformGB/T5009.19-1996
DDT<0.2ppmConformGB/T5009.19-1996
Microbiology
Total Plate Count<1,000cfu/g17cfu/gAOAC 990.12, 18th
Total Yeast & Mold<100cfu/g3cfu/gFDA (BAM) Chapter 18, 8th Ed.
E. ColiNegativeNegativeAOAC 997.11, 18th
SalmonellaNegativeNegativeFDA (BAM) Chapter 5, 8th Ed.

Product Function

Pharmacological effects:
1, to improve cerebral blood circulation, increase cerebral blood flow, reducing vascular resistance, increase the permeability of the blood-brain barrier, conducive to the prevention and treatment of cerebral thrombosis formation.
2, the expansion of the coronary artery and peripheral vascular, reducing myocardial oxygen consumption, to increase nutrition myocardial blood flow, improve myocardial microcirculation.
3, lower cholesterol, reduce high blood viscosity, platelet aggregation.
4, increasing the phagocytic function of the liver reticuloendothelial cells and macrophages, increased blood CAMP content, improve the immune system.
5, inhibition of intravascular coagulation, fibrinolysis promoting, reducing fibrinogen, and anti-tied thrombolysis.
Functions and Indications:
The blood stasis Tongluozhitong. Suitable for hemiplegia, cerebral infarction, cerebral thrombus formation, sequelae of stroke, coronary heart disease, angina, ischemic heart disease, Alzheimer's the hyperviscosity, dizziness psychosis.




Quality health care product nutrition supplement breviscapine with best price for sale
Send your message to this supplier
 
*From:
*To: Complex Nature Biotechnology CO., LTD.
*Subject:
*Message:
Characters Remaining: (0/3000)
 
Inquiry Cart 0